These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 35413821)

  • 1. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis.
    Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z
    BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
    Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG
    Front Immunol; 2020; 11():1281. PubMed ID: 32765489
    [No Abstract]   [Full Text] [Related]  

  • 3. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
    Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
    J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.
    Yin X; Wu Q; Hao Z; Chen L
    Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis.
    Zhang M; Zhou Z; Liu Z; Liu F; Zhao C
    PeerJ; 2022; 10():e12768. PubMed ID: 35111402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening the Significant Hub Genes by Comparing Tumor Cells, Normoxic and Hypoxic Glioblastoma Stem-like Cell Lines Using Co-Expression Analysis in Glioblastoma.
    Güven E; Afzal M; Kazmi I
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA.
    Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
    Biomed Res Int; 2018; 2018():4246703. PubMed ID: 30356407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
    Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of candidate biomarkers for GBM based on WGCNA.
    Sun Q; Wang Z; Xiu H; He N; Liu M; Yin L
    Sci Rep; 2024 May; 14(1):10692. PubMed ID: 38724609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
    Yang A; Wang X; Hu Y; Shang C; Hong Y
    Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
    Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H
    Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of
    Lin H; Yang Y; Hou C; Zheng J; Lv G; Mao R; Xu P; Chen S; Zhou Y; Wang P; Zhou D
    Genet Test Mol Biomarkers; 2021 May; 25(5):334-345. PubMed ID: 33970702
    [No Abstract]   [Full Text] [Related]  

  • 15. SLC12A5 as a novel potential biomarker of glioblastoma multiforme.
    Chen J; Wang H; Deng C; Fei M
    Mol Biol Rep; 2023 May; 50(5):4285-4299. PubMed ID: 36917367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Gene Expression Data-Driven Identification of Molecular Signatures, Prognostic Biomarkers, and Drug Targets for Glioblastoma.
    Alom MW; Jibon MDK; Faruqe MO; Rahman MS; Akter F; Ali A; Rahman MM
    Biomed Res Int; 2024; 2024():6810200. PubMed ID: 39184354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme.
    Kabir F; Apu MNH
    Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.
    Dong C; Fan W; Fang S
    J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-negative matrix factorization and differential expression analyses identify hub genes linked to progression and prognosis of glioblastoma multiforme.
    Akçay S; Güven E; Afzal M; Kazmi I
    Gene; 2022 May; 824():146395. PubMed ID: 35283227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Gene Co-Expression Network to Identify the Role of CD8 + T Cell Infiltration-Related Biomarkers in High-Grade Glioma.
    Feng P; Li Y; Tian Z; Qian Y; Miao X; Zhang Y
    Int J Gen Med; 2022; 15():1879-1890. PubMed ID: 35228815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.